
    
      Primary objective:

      - To assess the safe usability of the VIBEX MTX device for subcutaneous (SC) self-injection
      of methotrexate (MTX) in adult patients with rheumatoid arthritis (RA) after standardized
      training by site personnel and review of written instructions

      Secondary objectives:

        -  To evaluate the reliability and robustness of the VIBEX MTX device

        -  To evaluate the safety and local tolerance of an SC self-injection of MTX using the
           VIBEX MTX device

        -  To evaluate the effectiveness and ease of use of the VIBEX MTX device patient education
           tools for SC self-injection
    
  